Recent reports have provided evidence that the extracellular domain of CAIX can be released into body fluids of patients with kidney or bladder cancers and a high CAIX plasma level was associated with poor prognosis in these patients (Zavada et al, 2003; Hyrsl et al, 2009). Here, CA9 is linked to urinary bladder cancer.